Regulatory Affairs Professionals Society· @RAPSorg · X·· 13 天前精选AI 评分60
AI 导读
美国FDA一名负责执法的高级官员表示,FDA在2026财年对印度和中国开展的药品飞行检查数量较上一财年增加。该官员未在披露中给出具体检查次数。原文链接:https://hubs.la/Q04DfkBZ0
推荐理由
FDA官员披露2026财年在印度和中国的药品飞行检查数量增加,反映其海外生产监管取向的变化。
正文
A top US FDA enforcement official announced that the agency conducted more unannounced drug inspections in India and China in FY 2026 compared to the previous year.
https://hubs.la/Q04DfkBZ0
来源:Regulatory Affairs Professionals Society · x.com